|
gptkbp:instanceOf
|
gptkb:muscle_relaxant
gptkb:drug
|
|
gptkbp:approvedBy
|
1957
|
|
gptkbp:ATCCode
|
M03BA03
|
|
gptkbp:brand
|
gptkb:Robaxin
|
|
gptkbp:CASNumber
|
532-03-6
|
|
gptkbp:contraindication
|
hypersensitivity to methocarbamol
|
|
gptkbp:developedBy
|
gptkb:A.H._Robins_Company
|
|
gptkbp:eliminationHalfLife
|
1–2 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:hasMolecularFormula
|
C11H15NO5
|
|
gptkbp:interactsWith
|
gptkb:beer
gptkb:CNS_depressants
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
gptkb:central_nervous_system_depressant
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
241.24 g/mol
|
|
gptkbp:notRecommendedFor
|
children under 16 years
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
4106
3964
DB00423
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
|
|
gptkbp:sideEffect
|
nausea
dizziness
headache
blurred vision
drowsiness
|
|
gptkbp:UNII
|
WL5G6T62JX
|
|
gptkbp:usedFor
|
muscle spasms
musculoskeletal pain
|
|
gptkbp:bfsParent
|
gptkb:Muscle_Relaxants,_Central
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
methocarbamol
|